Next Article in Journal
Identification of Antibacterial Peptide Candidates Encrypted in Stress-Related and Metabolic Saccharomyces cerevisiae Proteins
Next Article in Special Issue
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
Previous Article in Journal
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
Previous Article in Special Issue
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(2), 165; https://doi.org/10.3390/ph15020165
Action Date Notes Link
article pdf uploaded. 28 January 2022 14:28 CET Version of Record https://www.mdpi.com/1424-8247/15/2/165/pdf-vor
article supplementary file uploaded. 28 January 2022 14:28 CET - https://www.mdpi.com/1424-8247/15/2/165#supplementary
article xml file uploaded 10 February 2022 07:48 CET Original file -
article xml uploaded. 10 February 2022 07:48 CET Update https://www.mdpi.com/1424-8247/15/2/165/xml
article pdf uploaded. 10 February 2022 07:48 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/165/pdf
article html file updated 10 February 2022 07:49 CET Original file -
article html file updated 31 July 2022 07:26 CEST Update https://www.mdpi.com/1424-8247/15/2/165/html
Back to TopTop